Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
Dalfampridine prior authorization program: a cohort study.
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
Treatment of multiple sclerosis in children and its challenges.
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
Surgical Outcomes of Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
Trigeminal neuralgia: New classification and diagnostic grading for practice and research.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Analysis of prognostic factors associated with longitudinally extensive transverse myelitis.
Pages
« first
‹ previous
…
346
347
348
349
350
351
352
353
354
…
next ›
last »